H. Wang

Low-Dose Paclitaxel Combined with Dehydrocavidine Synergistically Suppresses Cervical Cancer by Inhibiting FASN/SCD1-Mediated Lipid Metabolism

Cervical cancer is a leading cause of cancer-related death among women, and acquired resistance to paclitaxel (PTX) frequently results in treatment failure. Dehydrocavidine (DHC), the principal bioactive alkaloid from the traditional Chinese herb Corydalis saxicola, has shown ant...